Earnings
VRNA
8.53
-6.16%
-0.56
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
187.99M
0.00
--
--
--
--
8.26M
--
--
--
4.54M
1.72M
202.50M
1.16M
--
--
--
545.00K
--
--
--
1.70M
204.21M
--
178.00K
0.00
--
--
--
--
--
11.66M
--
--
--
2.36M
14.20M
4.63M
--
--
--
514.00K
5.15M
19.35M
31.79M
366.41M
-207.05M
-1.70M
--
--
184.85M
184.85M
204.21M
FY 2019-12-31
30.40M
10.37M
--
--
--
--
11.74M
--
--
--
1.73M
--
54.24M
1.34M
--
--
--
584.50K
3.65M
--
--
5.58M
59.82M
--
1.93M
0.00
--
--
--
--
--
9.02M
--
--
--
1.19M
12.75M
650.77K
--
--
--
1.54M
2.19M
14.94M
6.98M
157.54M
-119.63M
--
--
--
44.88M
44.88M
59.82M
FY 2019-12-31
30.43M
10.38M
--
--
--
--
9.81M
--
--
--
1.66M
2.02M
54.30M
1.35M
--
--
--
585.00K
--
--
--
1.94M
56.23M
--
1.93M
0.00
--
--
--
--
--
9.58M
--
--
--
1.33M
12.84M
0.00
--
--
--
652.00K
652.00K
13.49M
7.26M
179.53M
-141.78M
0.00
--
--
42.74M
42.74M
56.23M
FY 2018-12-31
25.22M
57.27M
--
--
--
--
7.14M
--
--
--
1.74M
--
91.37M
26.77K
--
--
--
562.27K
3.34M
--
--
3.93M
95.30M
--
3.62M
0.00
--
--
--
--
--
6.22M
--
--
--
3.19M
13.04M
0.00
--
--
--
1.41M
1.41M
14.44M
6.71M
151.55M
-77.41M
--
--
--
80.86M
80.86M
95.30M
FY 2018-12-31
27.17M
61.68M
--
--
--
--
7.69M
--
--
--
1.87M
--
98.41M
28.84K
--
--
--
605.58K
3.60M
--
--
4.23M
102.64M
--
3.90M
0.00
--
--
--
--
--
6.70M
--
--
--
3.44M
14.04M
0.00
--
--
--
1.51M
1.51M
15.55M
7.23M
163.22M
-83.37M
--
--
--
87.09M
87.09M
102.64M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out VRNA latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Verona Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.